Artelo Biosciences Stock Forecast - Simple Regression
| ARTL Stock | USD 1.69 0.04 2.31% |
Artelo Stock outlook is based on your current time horizon. Although Artelo Biosciences' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Artelo Biosciences' systematic risk associated with finding meaningful patterns of Artelo Biosciences fundamentals over time.
As of now, the relative strength index (RSI) of Artelo Biosciences' share price is approaching 42. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Artelo Biosciences, making its price go up or down. Momentum 42
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.57) | EPS Estimate Current Year (12.11) | EPS Estimate Next Year (3.28) | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.82) |
Using Artelo Biosciences hype-based prediction, you can estimate the value of Artelo Biosciences from the perspective of Artelo Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Artelo Biosciences on the next trading day is expected to be 1.32 with a mean absolute deviation of 0.24 and the sum of the absolute errors of 14.68. Artelo Biosciences after-hype prediction price | USD 1.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Artelo Biosciences to cross-verify your projections. Artelo Biosciences Additional Predictive Modules
Most predictive techniques to examine Artelo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Artelo using various technical indicators. When you analyze Artelo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Artelo Biosciences Simple Regression Price Forecast For the 27th of January
Given 90 days horizon, the Simple Regression forecasted value of Artelo Biosciences on the next trading day is expected to be 1.32 with a mean absolute deviation of 0.24, mean absolute percentage error of 0.11, and the sum of the absolute errors of 14.68.Please note that although there have been many attempts to predict Artelo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Artelo Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Artelo Biosciences Stock Forecast Pattern
| Backtest Artelo Biosciences | Artelo Biosciences Price Prediction | Buy or Sell Advice |
Artelo Biosciences Forecasted Value
In the context of forecasting Artelo Biosciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Artelo Biosciences' downside and upside margins for the forecasting period are 0.02 and 9.70, respectively. We have considered Artelo Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Artelo Biosciences stock data series using in forecasting. Note that when a statistical model is used to represent Artelo Biosciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.8841 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2407 |
| MAPE | Mean absolute percentage error | 0.1297 |
| SAE | Sum of the absolute errors | 14.6816 |
Predictive Modules for Artelo Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Artelo Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Artelo Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Artelo Biosciences After-Hype Price Density Analysis
As far as predicting the price of Artelo Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Artelo Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Artelo Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Artelo Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Artelo Biosciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Artelo Biosciences' historical news coverage. Artelo Biosciences' after-hype downside and upside margins for the prediction period are 0.08 and 10.04, respectively. We have considered Artelo Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Artelo Biosciences is risky at this time. Analysis and calculation of next after-hype price of Artelo Biosciences is based on 3 months time horizon.
Artelo Biosciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Artelo Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Artelo Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Artelo Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.81 | 8.37 | 0.09 | 0.07 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.69 | 1.60 | 5.33 |
|
Artelo Biosciences Hype Timeline
Artelo Biosciences is presently traded for 1.69. The entity has historical hype elasticity of -0.09, and average elasticity to hype of competition of -0.07. Artelo is anticipated to decline in value after the next headline, with the price expected to drop to 1.6. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -5.33%, whereas the daily expected return is presently at -0.81%. The volatility of related hype on Artelo Biosciences is about 9964.29%, with the expected price after the next announcement by competition of 1.62. The company has price-to-book (P/B) ratio of 0.5. Some equities with similar Price to Book (P/B) outperform the market in the long run. Artelo Biosciences recorded a loss per share of 19.5. The entity last dividend was issued on the 21st of June 2019. The firm had 1:6 split on the 13th of June 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Historical Fundamental Analysis of Artelo Biosciences to cross-verify your projections.Artelo Biosciences Related Hype Analysis
Having access to credible news sources related to Artelo Biosciences' direct competition is more important than ever and may enhance your ability to predict Artelo Biosciences' future price movements. Getting to know how Artelo Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Artelo Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GTBP | GT Biopharma | (0.05) | 10 per month | 6.78 | 0.02 | 10.84 | (10.45) | 51.03 | |
| PTIX | Protagenic Therapeutics | (0.09) | 9 per month | 0.00 | (0.22) | 12.73 | (14.00) | 58.73 | |
| CARM | Carisma Therapeutics | (0.19) | 29 per month | 9.30 | 0.06 | 22.92 | (14.06) | 62.59 | |
| SLRX | Salarius Pharmaceuticals | (0.02) | 8 per month | 0.00 | (0.16) | 16.00 | (16.92) | 66.01 | |
| PBM | Psyence Biomedical Ltd | (0.59) | 8 per month | 0.00 | (0.24) | 8.10 | (13.79) | 96.66 | |
| REVB | Revelation Biosciences | (0.05) | 10 per month | 0.00 | (0.19) | 5.56 | (8.57) | 20.39 | |
| LIPO | Lipella Pharmaceuticals Common | (0.15) | 22 per month | 0.00 | (0.15) | 17.07 | (16.00) | 44.95 | |
| SPRC | Scisparc | (0.12) | 7 per month | 0.00 | (0.37) | 4.46 | (12.20) | 30.69 | |
| SLXN | Biomotion Sciences Ordinary | 0.41 | 6 per month | 0.00 | (0.11) | 15.09 | (8.19) | 37.24 | |
| WINT | Windtree Therapeutics | 0.01 | 7 per month | 0.00 | (0.18) | 20.00 | (20.00) | 58.33 |
Other Forecasting Options for Artelo Biosciences
For every potential investor in Artelo, whether a beginner or expert, Artelo Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Artelo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Artelo. Basic forecasting techniques help filter out the noise by identifying Artelo Biosciences' price trends.Artelo Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Artelo Biosciences stock to make a market-neutral strategy. Peer analysis of Artelo Biosciences could also be used in its relative valuation, which is a method of valuing Artelo Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Artelo Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Artelo Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Artelo Biosciences shares will generate the highest return on investment. By undertsting and applying Artelo Biosciences stock market strength indicators, traders can identify Artelo Biosciences entry and exit signals to maximize returns.
Artelo Biosciences Risk Indicators
The analysis of Artelo Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Artelo Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting artelo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.32 | |||
| Standard Deviation | 8.25 | |||
| Variance | 68.04 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Artelo Biosciences
The number of cover stories for Artelo Biosciences depends on current market conditions and Artelo Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Artelo Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Artelo Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Artelo Biosciences Short Properties
Artelo Biosciences' future price predictability will typically decrease when Artelo Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Artelo Biosciences often depends not only on the future outlook of the potential Artelo Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Artelo Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.2 M | |
| Cash And Short Term Investments | 2.3 M |
Check out Historical Fundamental Analysis of Artelo Biosciences to cross-verify your projections. For more information on how to buy Artelo Stock please use our How to buy in Artelo Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Artelo Biosciences. If investors know Artelo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Artelo Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Artelo Biosciences is measured differently than its book value, which is the value of Artelo that is recorded on the company's balance sheet. Investors also form their own opinion of Artelo Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Artelo Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Artelo Biosciences' market value can be influenced by many factors that don't directly affect Artelo Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Artelo Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Artelo Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Artelo Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.